Profiling the metabolites produced by cells in Richter transformation could help researchers develop new targeted therapies in the future. Dr. Prajish Iyer from City of Hope National Comprehensive Cancer and colleagues presented the results at the American Society for Hematology (ASH) Annual Meeting 2024.